ES2155782A1 - Lactic acid bacteria used in the preparation of orally-administrable fermented milks for the treatment of temporarily-depressed immunity levels in individuals subjected to physiological stress - Google Patents
Lactic acid bacteria used in the preparation of orally-administrable fermented milks for the treatment of temporarily-depressed immunity levels in individuals subjected to physiological stressInfo
- Publication number
- ES2155782A1 ES2155782A1 ES9901036A ES9901036A ES2155782A1 ES 2155782 A1 ES2155782 A1 ES 2155782A1 ES 9901036 A ES9901036 A ES 9901036A ES 9901036 A ES9901036 A ES 9901036A ES 2155782 A1 ES2155782 A1 ES 2155782A1
- Authority
- ES
- Spain
- Prior art keywords
- preparation
- lactic acid
- acid bacteria
- levels
- individuals
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
Use of lactic acid bacteria in the preparation of fermented milks used to treat temporarily reduced levels of immune activity.This invention refers to a new use of lactic acid bacteria in the preparation of fermented milks used to treat temporarily reduced levels of immune activity by recovering depressed levels of immune activity with respect to the level that may be regarded as normal, above all, in healthy individuals who have been subject to intense exertion, or in general, to raised levels of physiological demand, as a direct result of physical exertion, or caused by psychologically tense situations.< IMAGE >Administration of a fermented milk containing Lactobacillus casei to achieve a simultaneous less pronounced decrease in the level of immune activity and a more rapid restoration of this level in individuals in athletes or other individuals in a satisfactory state of health engaging in intensive training and/or sporting trials : Lactic acid bacteria are used in the preparation of fermented milks, for the prevention and treatment of temporarily-depressed immune levels in individuals subjected to physiological stress.
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES009901036A ES2155782B1 (en) | 1999-05-07 | 1999-05-07 | USE OF ACIDOLACTIC BACTERIES TO PREPARE FERMENTED MILKS FOR THE TREATMENT OF TRANSITORALLY REDUCED IMMUNITY ACTIVITY LEVELS. |
DK00935083T DK1178730T3 (en) | 1999-05-07 | 2000-05-05 | Use of lactic acid bacteria for the production of fermented milk products for the treatment of weakened immunity levels |
DE60018919T DE60018919T2 (en) | 1999-05-07 | 2000-05-05 | USE OF MILK ACID BACTERIA IN THE MANUFACTURE OF FERMENTED DAIRY PRODUCTS FOR THE TREATMENT OF REDUCED IMMUNITY LEVELS |
MXPA01011336A MXPA01011336A (en) | 1999-05-07 | 2000-05-05 | Use of lactic acid bacteria in the preparation of fermented milks for the treatment of depressed immunity levels. |
AT00935083T ATE291353T1 (en) | 1999-05-07 | 2000-05-05 | USE OF LACTIC ACID BACTERIA IN THE PRODUCTION OF FERMENTED MILK PRODUCTS TO TREAT REDUCED IMMUNITY LEVELS |
PCT/EP2000/004593 WO2000067583A2 (en) | 1999-05-07 | 2000-05-05 | Use of lactic acid bacteria in the preparation of fermented milks for the treatment of depressed immunity levels |
ES00935083T ES2238285T3 (en) | 1999-05-07 | 2000-05-05 | USE OF ACIDOLACTIC BACTERIES IN THE PREPARATION OF FERMENTED MILKS FOR THE TREATMENT OF REDUCED IMMUNE LEVELS. |
AU50695/00A AU5069500A (en) | 1999-05-07 | 2000-05-05 | Use of lactic acid bacteria in the preparation of fermented milks for the treatment of depressed immunity levels |
EP00935083A EP1178730B1 (en) | 1999-05-07 | 2000-05-05 | Use of lactic acid bacteria in the preparation of fermented milks for the treatment of depressed immunity levels |
PT00935083T PT1178730E (en) | 1999-05-07 | 2000-05-05 | USE OF LACTICAL ACID BACTERIA IN THE PREPARATION OF BREASTFEEDS FOR THE TREATMENT OF IMMUNITY LEVELS DEPRESSED |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES009901036A ES2155782B1 (en) | 1999-05-07 | 1999-05-07 | USE OF ACIDOLACTIC BACTERIES TO PREPARE FERMENTED MILKS FOR THE TREATMENT OF TRANSITORALLY REDUCED IMMUNITY ACTIVITY LEVELS. |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2155782A1 true ES2155782A1 (en) | 2001-05-16 |
ES2155782B1 ES2155782B1 (en) | 2002-05-16 |
Family
ID=8308409
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES009901036A Expired - Fee Related ES2155782B1 (en) | 1999-05-07 | 1999-05-07 | USE OF ACIDOLACTIC BACTERIES TO PREPARE FERMENTED MILKS FOR THE TREATMENT OF TRANSITORALLY REDUCED IMMUNITY ACTIVITY LEVELS. |
Country Status (1)
Country | Link |
---|---|
ES (1) | ES2155782B1 (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998023727A1 (en) * | 1996-11-29 | 1998-06-04 | Bio K + International Inc. | Lactic ferment comprising a particular strain of lactobacillus acidophilus and use thereof |
WO1999010476A1 (en) * | 1997-08-21 | 1999-03-04 | New Zealand Dairy Board | Immunity enhancing lactic acid bacteria |
-
1999
- 1999-05-07 ES ES009901036A patent/ES2155782B1/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998023727A1 (en) * | 1996-11-29 | 1998-06-04 | Bio K + International Inc. | Lactic ferment comprising a particular strain of lactobacillus acidophilus and use thereof |
WO1999010476A1 (en) * | 1997-08-21 | 1999-03-04 | New Zealand Dairy Board | Immunity enhancing lactic acid bacteria |
Non-Patent Citations (4)
Title |
---|
OUWEHAND A C et al.: "The health effects of cultured milk products with viable and non-viable bacteria". INTERNATIONAL DAIRY JOURNAL 8 (9) 749-758, 1998. Pagina 749, columna 1; pagina 751, columna 1. * |
PERDIGON G et al.: "PREVENTION OF GASTROINTESTINAL INFECTION USING IMMUNOBIOLOGICAL METHODS WITH MILK FERMENTED WITH LACTOBACILLUS CASEI AND LACTOBACILLUS ACIDOPHILUS". JOURNAL DAIRY RESEARCH, CAMBRIDGE, GB, Vol. 57, 1990, paginas 255-264, XP000916913. Paginas 255-256. * |
PERDIGON G. et al.: Systemic and Local augmentation of the Immune Response in Mice by feeding with milk fermented with Lactobacillus acidophilus and/or Lactobacillus casei". Foods, Nutrition and Immunity. Dyn Nut Res., Basel, Karger, 1992, Vol. 1, paginas 66-77. Paginas 66,67. * |
SALJI J: "Acidophilus milk products: foods with a third dimension". FOOD SCIENCE & TECHNOLOGY TODAY 1992 45 PURBECK CLOSE, BEDFORD MK41 9LX, UK, Vol. 6, no 3, paginas 142-147, XP000952420. Pagina 146; tabla 2. * |
Also Published As
Publication number | Publication date |
---|---|
ES2155782B1 (en) | 2002-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2787544C (en) | Probiotic composition for use in the treatment of bowel inflammation | |
Nagao et al. | Effects of a fermented milk drink containing Lactobacillus casei strain Shirota on the immune system in healthy human subjects | |
ATE534396T1 (en) | PROBIOTIC MICROORGANISMS TO IMPROVE MUSCULAR FUNCTION | |
Lloyd et al. | Mouthguards and their use in sports: report of the 1st International Sports Dentistry Workshop, 2016 | |
JP2019135254A5 (en) | ||
WO2002007533A3 (en) | Nutritional composition | |
HK1090289A1 (en) | Antiallergic composition | |
US8246946B2 (en) | Treatment of bipolar disorder utilizing anti-fungal compositions | |
WO2004085628A8 (en) | Lactic acid utilising bacteria and their therapeutic use | |
WO2007038623A3 (en) | Oral formulation for enteric disorders and/or rehydration | |
Buzzard | Physiotherapy for the prevention of articular contraction in haemophilia | |
NZ599302A (en) | Preventing diseases in infants delivered via caesarean section | |
Sato et al. | Comparison of once and twice weekly water exercise on various bodily functions in community-dwelling frail elderly requiring nursing care | |
JP2008179601A (en) | Cosmetic composition containing bacterium of genus lactobacillus | |
HUP0200206A2 (en) | Lactic acid bacteria strains capable of preventing diarrhoea | |
JP6986067B2 (en) | Leuconostoc Holzapferii strain having the ability to prevent alopecia, promote hair growth or improve sexual function, and a composition containing the same. | |
CA2490896A1 (en) | Antiallergic agent, utilization thereof for reducing allergy and method of reducing allergy | |
Baghbadorani et al. | The effect of oral sensorimotor stimulations on feeding performance in children with spastic cerebral palsy | |
Onyenweaku et al. | Research Article Health Benefits of Probiotics | |
CN108576223A (en) | A kind of adult's probiotics solid beverage formula | |
ES2155782A1 (en) | Lactic acid bacteria used in the preparation of orally-administrable fermented milks for the treatment of temporarily-depressed immunity levels in individuals subjected to physiological stress | |
JP6640803B2 (en) | Composition for suppressing or improving eye fatigue | |
Noh et al. | Changes in pain, swelling, and range of motion according to physical therapy intervention after total knee arthroplasty in elderly patients | |
CN106666748A (en) | Health food composition with effect of reducing cholesterol | |
Ranganathan et al. | PREVENTING DENTAL CARIES-THE PROBIOTIC APPROACH. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EC2A | Search report published |
Date of ref document: 20010516 Kind code of ref document: A1 Effective date: 20010516 |
|
FD2A | Announcement of lapse in spain |
Effective date: 20180807 |